Pharmacovigilance for clinical trials in India: Current practice and areas for reform

Keeping in mind India’s increasing participation in multinational trials, this article explores potential areas of Indian pharmacovigilance, requiring reform and provides recommendations for building a robust safety reporting system. Internal discrepancies exist between Schedule Y and Central Drugs...

Descripción completa

Detalles Bibliográficos
Autores principales: Brahmachari, Ballari, Fernandes, Melanie, Bhatt, Arun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications 2011
Materias:
Pharmacovigilance
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3121263/
https://www.ncbi.nlm.nih.gov/pubmed/21731854
http://dx.doi.org/10.4103/2229-3485.80366

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3121263/
https://www.ncbi.nlm.nih.gov/pubmed/21731854
http://dx.doi.org/10.4103/2229-3485.80366

Ejemplares similares